These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 5301950)
1. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity]. Lobato DS; da Silveira DD Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950 [No Abstract] [Full Text] [Related]
2. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study. Truant AP; Olon LP; Cobb S Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111 [No Abstract] [Full Text] [Related]
3. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation]. Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457 [No Abstract] [Full Text] [Related]
4. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity]. Benedetti A; Busonera G; Cattano G Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163 [No Abstract] [Full Text] [Related]
5. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity. Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672 [No Abstract] [Full Text] [Related]
6. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
7. [Comparative evaluation of anoretics in weight reduction in obese patients]. Pietrzak J; Krotkiewski M Pol Tyg Lek; 1971 May; 26(20):756-8. PubMed ID: 5580931 [No Abstract] [Full Text] [Related]
8. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Steel JM; Munro JF; Duncan LJ Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610 [No Abstract] [Full Text] [Related]
13. The treatment of obesity. A call for prudence and professionalism. Kushner R Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914 [No Abstract] [Full Text] [Related]
14. [Controlled clinical trials of a new appetite-inhibiting drug]. Bani G; Barba C; Ricci G Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726 [No Abstract] [Full Text] [Related]
15. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies]. Takács L; Pethö B Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971 [No Abstract] [Full Text] [Related]
17. [Chlorphentermine in the treatment of obesity]. Chjnowski JR; Adamska-Dyniewska H; Leszczyński B; Mockallo T Pol Tyg Lek; 1968 Sep; 23(40):1531-3. PubMed ID: 5725611 [No Abstract] [Full Text] [Related]
18. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon? Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252 [TBL] [Abstract][Full Text] [Related]
19. A treatment for refractory obesity using fenfluramine without dietary restriction. Sedgwick JP Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744 [No Abstract] [Full Text] [Related]
20. [Trial of benzphetamine in treatment of obesity]. Plauchu M; Chapuy H; Pousset G; Amourdedieu J; Tuaillon J Lyon Med; 1969 Sep; 222(32):317-20. PubMed ID: 5398817 [No Abstract] [Full Text] [Related] [Next] [New Search]